<SEC-DOCUMENT>0001213900-24-022607-index.html : 20240314
<SEC-HEADER>0001213900-24-022607.hdr.sgml : 20240314
<ACCEPTANCE-DATETIME>20240314160901
ACCESSION NUMBER:		0001213900-24-022607
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20240314
DATE AS OF CHANGE:		20240314
EFFECTIVENESS DATE:		20240314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001359931
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				204580525
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-277931
		FILM NUMBER:		24750157

	BUSINESS ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		646-844-0337

	MAIL ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ArTara Therapeutics, Inc.
		DATE OF NAME CHANGE:	20200110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROTEON THERAPEUTICS INC
		DATE OF NAME CHANGE:	20060420
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ea0201586-s8_protara.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
Document 1 - file: ea0201586-s8_protara.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea020158601ex5-1_protara.htm
<DESCRIPTION>OPINION OF SULLIVAN & CROMWELL LLP.
<TEXT>
Document 2 - file: ea020158601ex5-1_protara.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea020158601ex23-1_protara.htm
<DESCRIPTION>CONSENT OF ERNST & YOUNG LLP
<TEXT>
Document 3 - file: ea020158601ex23-1_protara.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea020158601ex-fee_protara.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
Document 4 - file: ea020158601ex-fee_protara.htm

</DOCUMENT>
</SEC-DOCUMENT>